Cell rejuvenation company developing novel mRNA medicines for untreatable age-related conditions via epigenetic reprogramming. Founded in 2018. Proprietary ERA (Epigenetic Reprogramming of Age) methodology and eTurna RNA delivery system. Backed by Astellas Pharma. *Catalogued by Claude* On this page you can view the company profile, browse linked jobs, products, posts, and ventures, inspect verification and contact details, follow related identity links.